D. E. Shaw & Co., Inc. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$6,373,121
+23.7%
40,080
+10.0%
0.01%
+20.0%
Q2 2023$5,152,115
+100.0%
36,421
+138.0%
0.01%
+66.7%
Q1 2023$2,575,908
-48.9%
15,300
-48.6%
0.00%
-40.0%
Q4 2022$5,041,882
-50.6%
29,779
-45.4%
0.01%
-58.3%
Q3 2022$10,196,000
+19.8%
54,492
+4.0%
0.01%
+20.0%
Q2 2022$8,510,000
+0.6%
52,402
+16.5%
0.01%
+25.0%
Q1 2022$8,459,000
-22.7%
44,969
+8.8%
0.01%
-11.1%
Q4 2021$10,948,000
+39.9%
41,339
+52.7%
0.01%
+50.0%
Q3 2021$7,823,000
+158.4%
27,070
+73.8%
0.01%
+100.0%
Q1 2021$3,028,000
-62.0%
15,576
-62.5%
0.00%
-57.1%
Q4 2020$7,967,000
-54.5%
41,574
-64.9%
0.01%
-61.1%
Q3 2020$17,495,000
+444.8%
118,581
+356.4%
0.02%
+350.0%
Q2 2020$3,211,000
-34.8%
25,980
-49.1%
0.00%
-50.0%
Q1 2020$4,923,000
-59.0%
50,998
-60.7%
0.01%
-38.5%
Q4 2019$11,997,000
+32.1%
129,691
+9.5%
0.01%
+18.2%
Q3 2019$9,084,000
-50.4%
118,459
-44.4%
0.01%
-52.2%
Q2 2019$18,305,000
+17.4%
212,970
-19.3%
0.02%
+15.0%
Q1 2019$15,595,000
+10.9%
263,971
-1.0%
0.02%
+5.3%
Q4 2018$14,062,000
+576.1%
266,630
+611.0%
0.02%
+850.0%
Q3 2018$2,080,000
+593.3%
37,502
+352.9%
0.00%
Q1 2018$300,000
-77.7%
8,280
-77.6%
0.00%
-100.0%
Q4 2017$1,343,000
+386.6%
37,019
+413.7%
0.00%
Q3 2017$276,000
-88.4%
7,206
-87.5%
0.00%
-100.0%
Q2 2017$2,387,000
+84.5%
57,601
+56.7%
0.00%
+100.0%
Q1 2017$1,294,000
+7.2%
36,760
-6.1%
0.00%0.0%
Q4 2016$1,207,000
+220.2%
39,149
+213.8%
0.00%
+100.0%
Q3 2016$377,000
-19.3%
12,474
-28.4%
0.00%0.0%
Q1 2016$467,000
-25.4%
17,424
-44.9%
0.00%0.0%
Q4 2014$626,000
-67.1%
31,600
-67.0%
0.00%
-50.0%
Q3 2014$1,905,000
-11.4%
95,700
+1.5%
0.00%
-33.3%
Q2 2014$2,149,000
-5.9%
94,300
-46.9%
0.00%0.0%
Q1 2014$2,283,000
+183.6%
177,504
+200.4%
0.00%
+200.0%
Q4 2013$805,000
+132.7%
59,091
+89.6%
0.00%0.0%
Q3 2013$346,00031,1670.00%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders